An MRI and proton spectroscopy study of the thalamus in children with autism.
Thalamic alterations have been reported in autism, but the relationships between these abnormalities and clinical symptoms, specifically sensory features, have not been elucidated. The goal of this investigation is to combine two neuroimaging methods to examine further the pathophysiology of thalamic anomalies in autism and to identify any association with sensory deficits. Structural MRI and multi-voxel, short echo-time proton magnetic resonance spectroscopy ((1)H MRS) measurements were collected from 18 male children with autism and 16 healthy children. Anatomical measurements of thalamic nuclei and absolute concentration levels of key (1)H MRS metabolites were obtained. Sensory abnormalities were assessed using a sensory profile questionnaire. Lower levels of N-acetylaspartate (NAA), phosphocreatine and creatine, and choline-containing metabolites were observed on the left side in the autism group compared with controls. No differences in thalamic volumes were observed between the two groups. Relationships, although limited, were observed between measures of sensory abnormalities and (1)H MRS metabolites. Findings from this study support the role of the thalamus in the pathophysiology of autism and more specifically in the sensory abnormalities observed in this disorder. Further investigations of this structure are warranted, since it plays an important role in information processing as part of the cortico-thalamo-cortical pathways.
Hardan
Antonio Y
AY
Department of Psychiatry and Behavioral Sciences, Stanford University, Stanford, CA, USA. hardanay@stanford.edu
Minshew
Nancy J
NJ
Melhem
Nadine M
NM
Srihari
Sumana
S
Jo
Booil
B
Bansal
Rahul
R
Keshavan
Matcheri S
MS
Stanley
Jeffrey A
JA
D000293:Adolescent; D001224:Aspartic Acid / Q000031:analogs & derivatives / Q000378:metabolism; D001321:Autistic Disorder / Q000175:diagnosis / Q000503:physiopathology*; D002648:Child; D002794:Choline / Q000378:metabolism; D003401:Creatine / Q000378:metabolism; D004292:Dominance, Cerebral / Q000502:physiology; D006801:Humans; D007091:Image Processing, Computer-Assisted; D008279:Magnetic Resonance Imaging; D009682:Magnetic Resonance Spectroscopy; D008297:Male; D010468:Perceptual Disorders / Q000175:diagnosis / Q000503:physiopathology; D010725:Phosphocreatine / Q000378:metabolism; D012016:Reference Values; D013788:Thalamus / Q000473:pathology / Q000503:physiopathology*
D010725:Phosphocreatine; D001224:Aspartic Acid; C000179:N-acetylaspartate; D003401:Creatine; D002794:Choline